Esperion to Participate in January Investor Meetings

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. AWK
4. TSLA
5. NVDA

6. GNK
7. USO
8. ARGX
9. RKLB
10. MU

Get Alerts ESPR Hot Sheet

Price: $3.18 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

ANN ARBOR, Mich., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced today that the Company plans to present at the J.P. Morgan 41st Annual Healthcare Conference as well as the LifeSci Partners 12th Annual Corporate Access Event. Both in-person events are taking place January 9-11th, 2023 in San Francisco, California.

J.P. Morgan 41st Annual Healthcare ConferenceSheldon Koenig, CEO, will be making a corporate presentation and hosting 1x1 institutional investor meetings.

Date/Time: January 11th, 2023, 1:30pm PTLocation: The Westin St. Francis Hotel in San Francisco; Georgian RoomClick here to access the webcast.

LifeSci Partners 12th Annual Corporate Access EventSheldon Koenig, CEO, Ben Halladay, CFO, and JoAnne Foody, CMO, will be hosting 1x1 institutional investor meetings.

Date/Time: January 9-10th, 2023Location: Beacon Grand Hotel in San FranciscoTo schedule a meeting on the online system managed by LifeSci Partners, please click here to register for the conference.

Esperion TherapeuticsEsperion works hard to make our medicines easy to get, easy to take, and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:Esperion Corporate Communications[email protected]